Articles Tagged With:
-
Asthma prevalence still surging, CDC says
-
Should you build or buy?
-
Build vs. buy: What's right for your disease management efforts?
-
Personal approach boosts mammograms
-
Prolonged Release Oxycodone-Naloxone for Treatment of Severe RLS
This 12-week, randomized, double-blind, placebo-controlled trial examined the combination of oxycodone and naloxone for treatment of severe restless legs syndrome in patients inadequately controlled by previous treatment. -
Inhaled Apomorphine as a Rescue Treatment in Parkinson's Disease
Inhaled apomorphine, at doses up to 0.8 mg, appears safe and well tolerated by patients with Parkinson's disease, but does not result in significant improvement in wearing "off" periods, at the tested doses. -
Efficacy of Continuous EEG Monitoring in Critical Care Units
Utilization of continuous EEG monitoring in mechanically ventilated patients in the ICU was associated with a reduction in hospital mortality without significantly affecting hospital costs or length of stay. -
Height and Bone Age in Treated Juvenile Myasthenia Gravis
In young children with myasthenia gravis, height and bone age are negatively impacted by chronic corticosteroid usage, but not by thymectomy. -
Neurology Alert - Full February 2014 Issue in PDF
-
Informed consent can play part in violence